India may consider restricting fluoroquinolone antibiotics just like the UK did

The MHRA said it conducted a thorough review into the effectiveness of current measures to reduce the risk of potentially long-term adverse reactions to fluoroquinolone antibiotics and has sought advice from the Commission on Human Medicines (CHM).

Related Keywords

United Kingdom ,India ,Glenmark Zinox ,Levofloxacin Levaquin ,Moxifloxacin Avelox ,Cipla Levoflox ,Ofloxacin Floxin ,Cipla Norflox ,Pharma Zenflox ,Sun Pharma Zanocin ,Gemifloxacin Factive ,Ipca Lab Normax ,Commission On Human Medicines ,Regulatory Agency ,United Kingdom Medicines ,Mankind Pharma ,Percin Tablet ,Sun Pharma ,Human Medicines ,Yellow Card ,